Dr. Li is an Associate Professor of Medicine at the Brigham and Women’s Hospital and Harvard Medical School.  He leads an active clinical and translational laboratory research program focused on viral persistence, reservoirs and resistance, especially within the fields of HIV and COVID-19.  Dr. Li is the Director of the Harvard/Brigham Virology Specialty Laboratory, the Director of the AIDS Clinical Trials Group Virology Core Laboratories, the Brigham and Women’s Hospital ID Fellowship Research Director, the Director of the Harvard University Center for AIDS Research Clinical Core, and a member of the NIH COVID-19 Treatment Guidelines Panel. He is the protocol Chair of several ACTG studies and the protocol virologist for the ACTIV-2 Adaptive Platform Treatment Trial for Outpatients with COVID-19. Dr. Li also serves as the Deputy Editor for the Journal of Infectious Diseases.